UK Town Centre gets an injection of gene therapy—hazardous chemicals and emissions galore

Stevenage had better think about the risks...

Does Stevenage Town Centre know what’s coming it’s way?

This is what’s coming down the line for Stevenage Town Centre:

Autolus Therapeutics’ CAR-T Cell Manufacturing Facility, Stevenage, UK

It begins:

“UK-based biotechnology company Autolus Therapeutics is building a facility, named The Nucleus, in Stevenage, UK, for the manufacturing of chimeric antigen receptor (CAR) T-cell therapies for cancer treatment.

The facility is intended to provide good manufacturing practice (GMP) capacity for the development and commercial supply of Autolus’ investigational CD19 CAR T-cell therapy, Obecabtagene autoleucel (Obe-cel, AUTO1).

The Cell and Gene Therapy Catapult facility, an existing cell and gene therapy manufacturing facility in Stevenage, is supporting the initial global commercial launch capacity for Obe-cel until the CAR T-cell production facility is opened.

The first construction phase of the facility was completed in record time in December 2022 and the facility is expected to begin GMP operations in the second half of 2023. It is expected to process 2,000 treatments each year and generate 400 job opportunities in Stevenage.”

What does Autolus have in the pipeline?

From the Autolus website we have their clinical trial pipeline,